Stimuli-responsive polyamine-DNA blend nanogels for co-delivery in cancer therapy

Colloids and Surfaces B: Biointerfaces

Volumn 132, Issue , 2015, Pages 194-201

  Costa, Diana ^a   Valente, Artur J M ^b   Queiroz, João ^a  

^a UNIVERSITY OF BEIRA INTERIOR   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Anticancer drugs; Cancer therapy; Co delivery; Gene delivery; Nanogels; Non viral vectors

Indexed keywords

CROSSLINKING; DISEASES; DNA; ETHYLENE; ETHYLENE GLYCOL; GENE TRANSFER; GENES; HYDROGELS; MOLECULAR BIOLOGY; NANOSTRUCTURED MATERIALS; ONCOLOGY;

ANTICANCER DRUG; CANCER THERAPY; CO DELIVERIES; GENE DELIVERY; NANOGELS; NONVIRAL VECTORS;

GENE THERAPY;

DOXORUBICIN; EPIRUBICIN; PACLITAXEL; PLASMID DNA; POLYAMINE; POLYETHYLENEIMINE; PROTEIN P53; TRANSFERRIN; DNA; GEL;

ADULT; ARTICLE; CANCER CELL; CANCER GENE THERAPY; CANCER INHIBITION; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; IN VITRO STUDY; NANOENCAPSULATION; PHOTODEGRADATION; PRIORITY JOURNAL; SURFACE PROPERTY; TUMOR SUPPRESSOR GENE; CHEMISTRY; GEL; NANOTECHNOLOGY; NEOPLASMS;

DNA; GELS; HUMANS; IN VITRO TECHNIQUES; NANOTECHNOLOGY; NEOPLASMS; POLYAMINES;

EID: 84936764313     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2015.04.064     Document Type: Article

References (48)

1. McTaggart S., Al-Rubeai M. Biotechnol. Adv. 2002, 20:1.
2. Dufes C., Keith W.N., Bilsland A., Proutski I., Uchegbu I.F., Schatzlein A.G. Cancer Res. 2005, 65:8079.
3. Park T.G., Jeong J.H., Kim S.W. Adv. Drug Deliv. Rev. 2006, 58:467.
4. Han H.D., Mora E.M., Roh J.W., Nishimura M., Lee S.J., Stone R.L., Bar-Eli M., Lopez-Berestein G., Sood A.K. Cancer Biol. Ther. 2011, 11:839.
5. Xu L., Li X., Takemura T., Hanagata N., Wu G., Chou L.L. J. Nanobiotechnol. 2012, 10:16.
6. Li H., Lakshmikanth T., Garofalo C., Enge M., Spinnler C., Anichini A., Szekely L., Kärre K., Carbone E., Selivanova G. Cell Cycle 2011, 10:3346.
7. Sasaki Y., Oshima Y., Koyama R., Tamura M., Kashima L., Idogawa M., Yamashita T., Toyota M., Imai K., Shinomura Y., Tokino T. Cancer Genet. Ther. 2012, 19:749.
8. Xu L., Pirollo K.F., Chang J. J. Controlled Release 2001, 74:115.
9. Koivusalo R., Krausz E., Helenius H., Hietanen S. Mol. Pharmacol. 2005, 68:372.
10. Li Y., Hua S., Xiao W., Wang H., Luo X., Li C., Cheng S., Zhang X., Zhuo R. J. Mater. Chem. 2011, 21:3100.
11. Chen S., Zhao D., Li F., Zhuo R., Cheng S. R. Soc. Chem. Adv. 2012, 2:1820.
12. Costa D., Valente A.J.M., Miguel M.G., Queiroz J.A. Macromol. Biosci. 2012, 12:1243.
13. Klinger D., Aschnbrenner E.M., Weiss C.K., Landfester K. Polym. Chem. 2012, 3:204.
14. Pan Y.J., Chen Y.Y., Wang D.R., Wei C., Guo J., Lu D.R., Chu C.C., Wang C.C. Biomaterials 2012, 33:6570.
15. Lee J., Jeong D., Seo S., Na K. J. Pharm. Invest. 2013, 43:63.
16. Davis M.E. Curr. Opin. Biotechnol. 2002, 13:128.
17. Vercauteren D., Rejman J., Martens T.F., Demeester J., De Smedt S.C., Braeckmans K. J. Controlled Release 2012, 161:581.
18. Gojgini S., Tokatlian T., Segura T. Mol. Pharm. 2011, 8:1582.
19. Noga M., Edinger D., Rödl W., Wagner E., Winter G., Besheer A. J. Controlled Release 2012, 159:92.
20. Kim T.H., Yu G.S., Choi H., Shim Y.J., Choi M.J.S. J. Nanosci. Nanotechnol. 2011, 11:1799.
21. Brgles M., Šantak M., Halassy B., Forcic D., Tomašić J. Int. J. Nanomed. 2012, 7:393.
22. Chang K.H., Bae Y.H. Biomaterials 2011, 32:4914.
23. Li Z., Yin H., Zhang Z., Liu K.L., Li J. Biomacromolecules 2012, 13:3162.
24. Morán M.C., Baptista F.R., Ramalho A., Miguel M.G., Lindman B. Soft Matter 2009, 5:2538.
25. Duan S-Y., Ge X-M., Lu N., Wu F., Yuan W., Jin T. Int. J. Nanomed. 2012, 7:3813.
26. Cao M., Deng X., Su S., Zhang F., Xiao X., Hu Q., Fu Y., Yang B.B., Wu Y., Sheng W., Zeng Y. Nanoscale 2013, 5:12120.
27. Wagner E., Curiel D., Cotton M. Adv. Drug Deliv. Rev. 1994, 14:113.
28. Kircheis R., Wightman L., Schreiber A., Robitza B., Rössler V., Kursa M., Wagner E. Gene Ther. 2001, 8:28.
29. Bremner K.H., Seymour L.W., Pouton C.W. Curr. Opin. Mol. Ther. 2001, 3:170.
30. Ogris M., Carlisle R.C., Bettinger T., Seymour L.W. J. Biol. Chem. 2001, 276:47550.
31. Bloomfield V.A. Curr. Opin. Struct. Biol. 1996, 6:334.
32. Korolev N., Lyubartsev A., Nordenskiold L. Adv. Colloid Interface Sci. 2010, 158:32.
33. Costa D., Valente A.J.M., Miguel M.G., Queiroz J.A. Langmuir 2011, 27:13780.
34. Costa D., Queiroz J.A., Miguel M.G., Lindman B. Colloids Surf. B: Biointerfaces 2012, 92:106.
35. Costa D., Valente A.J.M., Miguel M.G., Queiroz J.A. Adv. Colloid Interface Sci. 2014, 205:257.
36. Eriksson M., Kim S.K., Sen S., Gräslund A., Jernström B., Nordén B. J. Am. Chem. Soc. 1993, 115:1639.
37. Benasutti M., Ejadi S., Whitlow M.D., Loechler E.L. Biochemistry 1998, 27:472.
38. Porschke D. Biochemistry 1984, 81:36.
39. Raspaud E., Cruz M.O., Shikorav J.L., Livolant F. Biophys. J. 1998, 74:381.
40. Jorge A.F., Pereira R.F.P., Nunes S.C.C., Valente A.J.M., Dias R.S., Pais A.A.C.C. Biomacromolecules 2014, 15:478.
41. Petros R.A., DeSimone J.M. Nat. Rev. Drug Discov. 2010, 9:615.
42. Korsmeyer R.W., Gurny R., Docler E., Buri P., Peppas N.A. Int. J. Pharm. 1983, 15:25.
43. Costa D., Valente A.J.M., Pais A.A.C.C., Miguel M.G., Lindman B. Colloids Surf. A: Physicochem. Eng. Aspects 2010, 354:28.
44. Sriamornsak P., Sungthongjeen S. AAPS PharmSciTech 2007, 8:E51.
45. Möckel J.E., Lippold B.C. Pharm. Res. 1993, 10:1066.
46. Bossoni R., Riul A., Valente A.J.M., Rubira A.F., Muniz E.C. J. Braz. Chem. Soc. 2014, 25:1124.
47. Reis A.V., Guilherme M.R., Rubira A.F., Muniz E.C. J. Colloid Interface Sci. 2007, 310:128.
48. Valente A.J.M., Cruz S.M.A., Morán M.C., Murtinho D.B., Muniz E.C., Miguel M.G. Exp. Polym. Lett. 2010, 4:480.